SCHEMBL1793007

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL27854604	0.92	KMT2A (0.70)	GCKKMT2AMEN1MAPTLMNA
	SCHEMBL1791977	0.83	GCK (1.00)	GCKKMT2AMEN1RARARARB
	SCHEMBL2666298	0.82	GCK (0.84)	GCKKMT2AMEN1RARARARB
	SCHEMBL1790712	0.82	GCK (0.77)	GCKKMT2AMEN1RARARARB
	SCHEMBL2664545	0.81	NPC1 (0.71)	KMT2AMEN1MAPTLMNAHTT
	SCHEMBL30354968	0.81	NPC1 (0.71)	KMT2AMEN1MAPTLMNAHTT
	SCHEMBL1793859	0.80	GCK (0.73)	GCKKMT2AMEN1RARARARB
	SCHEMBL2652506	0.80	GCK (0.81)	GCKKMT2AMEN1RARARARB
	SCHEMBL1795449	0.80	GCK (0.48)	GCKKMT2AMEN1MAPTLMNA
	SCHEMBL1792248	0.79	GCK (0.54)	GCKKMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.